Navigation Links
Polypill for Heart Ailments Being Tested in India

The Dr Reddy's Laboratories (DRL), a leading Indian pharmaceutical firm, says it is conducting the first-ever clinical trials for an all-in-one polypill// for heart problems on 250 patients in the country. According to Raghu Cidambi of DRL, "We hope to put it in the market by the end of this year."

The proposed polypill will contain drugs for dilating arteries, relaxing heart muscles, removing excess water and salts, preventing clot formation, and reducing "bad" cholesterol.

The subjects of the trial have all already suffered a cardiac event. The trial is for establishing whether the polypill can prevent recurrence of cardiac problems.

Though a polypill was first suggested by two British scientists in 2003, this is the first time such a drug is being tested anywhere in the world on human subjects.

If the trials succeed, the polypill may have a worldwide market. Every year, over 17.5 million persons die due to heart diseases all over the world. India has the dubious distinction of having the largest share - over 1.5 million.

By 2010, India is projected to have 60% of the world's heart patients fuelled by risky lifestyles — which include junk food, lack of exercise and smoking — and the increasing number of elderly people.

The DRL is hoping to open up yet another vista. Even those who have not suffered an attack or a stroke could take the polypill if they think that they are liable to fall victim to cardio-vascular diseases.

Clinical trials to establish that aspect of the drug would start after necessary permission is granted by the Drug Controller of India.

However experts say such one-size-fits-all approach may not work. They note that dosage may vary from person to person.

Besides it could make people complacent about risk factors like smoking, diet, stress and exercise, they caution.
SR
'"/>




Page: 1

Related medicine news :

1. “Polypill”- to prevent recurrent heart diseass
2. Dr. Reddys To Launch Polypill For Treating Heart Disease
3. One in Three Heart Attack Patients Have No Chest Pains
4. Epileptic Seizures Can Be Due to Heart Problem
5. Bypass Heart Surgery Performed Without General Anesthesia
6. New CPR Guidelines issued by Heart Association
7. White Cells Count Can Predict Heart Attack Death Risk
8. Vitamins-The answer to Heart Disease?
9. Fight Heart disease and Pain with Meditation
10. Heart disease in the newborn is related to maternal malnutrition
11. New drug to treat Heart Attack and damaged tissue
Post Your Comments:
(Date:12/2/2008)...Newswire/ -- diaDexus, Inc. today,announced that ...mat of the,PLAC Test for Lp-PLA2. This automated ... a wide range of clinical chemistry analyzers, was...tration (FDA) in December 2007. diaDexus also,ann...st to Europe. , The PLAC Test is the only b...
(Date:12/2/2008)...t a symposium today hosted by Johns,Hopkins Univ...archers presented,the latest research in brain pl...cience into technology to improve lives. Henry Mah...vidence that cognitive intervention developed by,...brain,s ability to,reorganize itself throughout l...
(Date:12/2/2008)...ewswire/ -- Are you unhappy with your smile but ar...ailable? , , The Pennsylvania Dental Associ...ptions exist to improve your smile. Your dentist c... determine a suitable option to help restore your ...tal options. , , , , Tooth whi...
(Date:12/2/2008)...ed for 3.5 percent of high school athletes, injuri... to examine rare injuries and conditions of U.S. h...uries, dental injuries, neck and cervical injuries...t in high morbidity, costly surgeries and treatmen... associated with the highest rate of rare injuries...
Breaking Medicine News(10 mins):Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
...riggered by viral cold are common in preschoolers....since the frequency disappears by school age. //Th...r oral steroids at the first sign of an attack. Bu...ive is controversial. The research shows a course...
...be a major improvement for HIV patients in less-de...sess a patient's response to HIV medication.// HIV... This treatment is now becoming available in Afric...etermine the CD4 cell count are needed. A low CD4 ...
...to help acne patients. A new study highlights the ...is is important because this skin disease can lead...b and sometimes even suicide. Doctors from London ...ate facial acne. Thirty-one of the patients receiv...
...is year’s meeting of the American Society of Thera...ment //of external beam radiation may be what it t...ers that have spread to the bone. More than 160 ho... States and Canada were involved in a study of abo...
Other Medicine News:
(Date:12/1/2008)...st policy , , ROCHESTER, Minn., Dec. 1 /PR...ic finds the use of the drug therapy etanercept in...e inflammation of the liver caused by excessive co... published in the December issue of Gastroenterol... VIDEO ALERT: Additional audio and video resource...
(Date:12/1/2008)...rstCall/ -- Vical Incorporated (Nasdaq: VICL ) a...tone payment from Merck & Co., Inc. based on M...ial of an investigational plasmid DNA (pDNA) cance...,s DNA gene delivery technology and encodes human ... the subject of separate license agreement. , ...
(Date:11/27/2008)...acute lymphoblastic leukemia relapse cases arise f...s , , MEMPHIS, Tenn., Nov. 27 /PRNewswire-U...search Hospital have identified distinctive geneti...te lymphoblastic leukemia (ALL) that cause relapse...ents for ALL relapse in children and, ultimately, ...
(Date:11/25/2008)...wire-USNewswire/ -- Kleinert Kutz and University ....S. hand transplant on Messina, New York resident,...tal Hand Care Center on Monday, November 24. The ...pleted shortly after 9 p.m. in a record nine hours...bin/prnh/20081125/DC48555-a ) , (Photo: http:...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 1Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 2Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday May 14 2008 5202 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 2FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1
...IDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCel.... Beer, President and,Chief Executive Officer of V...ivities and product pipeline at the C.E. Unterberg...on Tuesday, July,10, 2007 at 3:00 p.m. at the Mand...webcast of the presentation will be available on,t...
...ESTER, Mass., Jun 27, 2007 (PrimeNewswire via COMT...ion (Nasdaq:GNBT), the,leader in drug delivery for...e mouth, announced today that it will be making th...g of the European,Society of Pediatric Endocrinolo...rget="_blank" href=,"http://www.espe2007.org/">www...
Other Medicine Technology:Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3
... integrated technology and service--mobile,outpati...heartbeat, ECG monitoring, analysis and response, ...y focused on helping physicians diagnose and treat...in diagnosing and treating arrhythmia. Delays can ...
...rmance temperature controlled shaker which accommo...eed and incubation time are fully programmable via...ed on the LCD in real time. Microprocessor-control... provide uniform incubation with less than 0.6 C v...
The iEMS Incubator/Shaker HT is designed for extended temperatures. Thus, the iEMS Incubator/Shaker HT is ideal for applications such as DNA hybridization and primer extension assays. iEMS Incubator/
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
Medicine Products: